Guo Rui, Shen Hong, Zhao zhenglan, et al. Influence of metoclopramide on capsule endoscopy:a Meta-analysis. [J]. Journal of Chongqing Medical University 41(6):620-623(2016)
Guo Rui, Shen Hong, Zhao zhenglan, et al. Influence of metoclopramide on capsule endoscopy:a Meta-analysis. [J]. Journal of Chongqing Medical University 41(6):620-623(2016) DOI: 10.13406/j.cnki.cyxb.000989.
Influence of metoclopramide on capsule endoscopy:a Meta-analysis
Objective:To evaluate the effect of metoclopramide on capsule endoscopy(CE)examination. Methods:The literature was searched from CNKI(January 2004 to September 2015)
VIP(January 2004 to September 2015)
WANFANG DATA(January 2004 to September 2015)
Pub Med(January 2004 to September 2015)
Cochrane Library(January 2004 to September 2015)
EMbase(January2004 to September 2015). The data were extracted
the quality of studies was evaluated according to the The Cochrane Handbook
and meta-analyses were performed using Rev Man 5.3 software. Results:Eight randomized controlled trials(RCTS)involving 627 patients were included in this study. The Meta-analyses showed that there was no significant difference between the metoclopramide group and control group in the rate of complete small bowel examination(CER)and the diagnostic yield(RR=1.11
95%CI=0.99 to 1.23
P=0.070;RR=1.10
95%CI=0.95 to 1.27
P=0.210). While
the gastric transit time(GTT)and the small bowel transit time(SBTT)of metoclopramide group were much shorter than that of control group(SMD=-0.32
95%CI=-0.48 to-0.16)
P=0.000;SMD=-0.35
95%CI=-0.65 to-0. 06
P =0. 020). Conclusion :Metoclopramide cannot enhance the complete rate and diagnostic rate of small bowel examination
moreover it has an adverse effect on the small bowel examination because it reduces the small bowel transit time.However
the defect in all 8 involved RCTs may affect the accuracy of the results
so more strictly multi-centered RCTs with high quality in large-scale are needed to confirm this result.